Authors:
Catargi, B
Breilh, D
Gin, H
Rigalleau, V
Saux, MC
Roger, P
Tabarin, A
Citation: B. Catargi et al., A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps, DIABETE MET, 27(3), 2001, pp. 323-327
Authors:
Gardet, V
Gatta, B
Simonnet, G
Tabarin, A
Chene, G
Ducassou, D
Corcuff, JB
Citation: V. Gardet et al., Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma, J HYPERTENS, 19(6), 2001, pp. 1029-1035
Citation: B. Catargi et al., Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump, DIABETE MET, 26(3), 2000, pp. 210-214
Authors:
Caron, P
Tabarin, A
Cogne, M
Chanson, P
Jaquet, P
Citation: P. Caron et al., Variable growth hormone profiles following withdrawal of long-term 30 mg slow-release lanreotide treatment in acromegalic patients: clinical implications, EUR J ENDOC, 142(6), 2000, pp. 565-571
Authors:
Tabarin, A
Achermann, JC
Recan, D
Bex, V
Bertagna, X
Christin-Maitre, S
Ito, M
Jameson, JL
Bouchard, P
Citation: A. Tabarin et al., A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism, J CLIN INV, 105(3), 2000, pp. 321-328
Authors:
Kuhn, JM
Arlot, S
Lefebvre, H
Caron, P
Cortet-Rudelli, C
Archambaud, F
Chanson, P
Tabarin, A
Goth, MI
Blumberg, J
Catus, F
Ispas, S
Beck-Peccoz, P
Citation: Jm. Kuhn et al., Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide, J CLIN END, 85(4), 2000, pp. 1487-1491
Authors:
Valli, N
Catargi, B
Ronci, N
Leccia, F
Guyot, M
Roger, P
Ducassou, D
Tabarin, A
Citation: N. Valli et al., Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodinescintigraphy, THYROID, 9(6), 1999, pp. 583-589
Authors:
Catargi, B
Leprat, F
Guyot, M
Valli, N
Ducassou, D
Tabarin, A
Citation: B. Catargi et al., Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome, EUR J ENDOC, 141(2), 1999, pp. 117-121
Authors:
Catargi, B
Raymond, JM
Lafarge-Gense, V
Leccia, F
Roger, P
Tabarin, A
Citation: B. Catargi et al., Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism, J ENDOC INV, 22(9), 1999, pp. 688-692
Authors:
Duclos, M
Corcuff, JB
Roger, P
Tabarin, A
Citation: M. Duclos et al., The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa, CLIN ENDOCR, 51(6), 1999, pp. 725-731
Authors:
Lefournier, V
Gatta, B
Martinie, M
Vasdev, A
Tabarin, A
Bessou, P
Berge, J
Bachelot, I
Chabre, O
Citation: V. Lefournier et al., One transient neurological complication (sixth nerve palsy) in 166 consecutive inferior petrosal sinus samplings for the etiological diagnosis of Cushing's syndrome, J CLIN END, 84(9), 1999, pp. 3401-3402
Authors:
Tabarin, A
Valli, N
Chanson, P
Bachelot, Y
Rohmer, V
Bex-Bachellerie, V
Catargi, B
Roger, P
Laurent, F
Citation: A. Tabarin et al., Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome, J CLIN END, 84(4), 1999, pp. 1193-1202
Authors:
Kraimps, JL
Bardet, S
Nocaudie-Calzada, M
Tabarin, A
Wemeau, JL
Citation: Jl. Kraimps et al., A practical guide to I-131-6 beta-iododomethyl-19-norcholesterol adrenal scintigraphy., ANN CHIR, 53(3), 1999, pp. 255-260
Authors:
Bardet, S
Nocaudie-Calzada, M
Kraimps, JL
Tabarin, A
Wemeau, JL
Citation: S. Bardet et al., Practical guideline for adrenal scintigraphy with I-131-6 beta-iodomethyl-19-norcholesterol, ANN ENDOCR, 59(4), 1998, pp. 344-353